login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
PHIBRO ANIMAL HEALTH CORP-A (PAHC) Stock News
USA
-
Nasdaq
- NASDAQ:PAHC -
US71742Q1067
-
Common Stock
41.63
USD
+0.82 (+2.01%)
Last: 11/21/2025, 8:00:02 PM
41.63
USD
0 (0%)
After Hours:
11/21/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
PAHC Latest News, Press Relases and Analysis
All
Press Releases
20 days ago - By: Chartmill
Phibro Animal Health Corp-A (NASDAQ:PAHC) Shows Strong Technical and Fundamental Momentum
3 days ago - By: Zacks Investment Research
- Mentions:
ATRO
COMM
HRTG
Zacks.com featured highlights include Phibro Animal Health, Astronics, CommScope and Heritage Insurance
4 days ago - By: Zacks Investment Research
- Mentions:
ALL
SANM
ENS
Four PEG-Driven GARP Winners for the Uncertainty of November 2025
4 days ago - By: Zacks Investment Research
Phibro (PAHC) Upgraded to Strong Buy: Here's What You Should Know
4 days ago - By: Zacks Investment Research
- Mentions:
BSX
PAHC or BSX: Which Is the Better Value Stock Right Now?
4 days ago - By: Zacks Investment Research
- Mentions:
ATRO
COMM
HRTG
4 Stocks Trading Near 52-Week High With More Upside Potential
4 days ago - By: Zacks Investment Research
- Mentions:
SHIP
BCAL
Best Momentum Stock to Buy for Nov. 20th
4 days ago - By: Zacks Investment Research
- Mentions:
FCFS
SHIP
Best Income Stocks to Buy for Nov. 20th
4 days ago - By: Zacks Investment Research
- Mentions:
FCFS
CMC
SHIP
BCAL
New Strong Buy Stocks for Nov. 20: CMC, BCAL, and More
7 days ago - By: Zacks Investment Research
Don't Overlook Phibro (PAHC) International Revenue Trends While Assessing the Stock
11 days ago - By: Zacks Investment Research
Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term
14 days ago - By: Zacks Investment Research
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock
17 days ago - By: Zacks Investment Research
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
18 days ago - By: Zacks Investment Research
Phibro (PAHC) Reports Q1 Earnings: What Key Metrics Have to Say
18 days ago - By: Zacks Investment Research
Phibro Animal Health (PAHC) Q1 Earnings and Revenues Top Estimates
19 days ago - By: Phibro Animal Health Corporation
Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance
19 days ago - By: Benzinga
- Mentions:
TECH
INSE
GEF
SKYT
...
Earnings Scheduled For November 5, 2025
20 days ago - By: Phibro Animal Health Corporation
Phibro Animal Health Corporation Declares Quarterly Dividend
20 days ago - By: Benzinga
A Preview Of Phibro Animal Health's Earnings
21 days ago - By: Zacks Investment Research
- Mentions:
PODD
LMAT
INFU
Can Strength in Rental Business Drive INFU Stock Before Q3 Earnings?
24 days ago - By: Zacks Investment Research
- Mentions:
EW
PODD
VCYT
EW Stock Gains on Q3 Earnings and Revenue Beat, Margins Crash
25 days ago - By: Phibro Animal Health Corporation
Phibro Animal Health Corporation Announces National Launch of Restoris™ Piezoelectric Dental Gel for Dogs
25 days ago - By: Zacks Investment Research
- Mentions:
ALGN
PODD
VCYT
ALGN Stock Up on Q3 Earnings and Revenue Beat, Margins Crash
25 days ago - By: Zacks Investment Research
- Mentions:
SNWV
Sanuwave Health Inc. (SNWV) to Report Q3 Results: Wall Street Expects Earnings Growth
26 days ago - By: Phibro Animal Health Corporation
Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results
26 days ago - By: Zacks Investment Research
Phibro Animal Health (PAHC) Earnings Expected to Grow: What to Know Ahead of Q1 Release
26 days ago - By: Zacks Investment Research
- Mentions:
PODD
CHE
VCYT
CHE Stock Falls on Q3 Earnings and Revenue Miss, Margins Crash
a month ago - By: Zacks Investment Research
- Mentions:
PODD
VCYT
ITGR
ITGR Shares Down Despite Q3 Earnings & Revenues Beat Estimates
a month ago - By: Zacks Investment Research
- Mentions:
BSX
PAHC or BSX: Which Is the Better Value Stock Right Now?
2 months ago - By: Phibro Animal Health Corporation
Phibro Animal Health Corporation Announces Licensing Agreement with Lighthouse Pharmaceuticals, Inc. for Innovative Periodontal Health Asset for Dogs
2 months ago - By: Zacks Investment Research
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term
2 months ago - By: Zacks Investment Research
- Mentions:
PDS
UGP
FUTU
PGY
New Strong Buy Stocks for September 30th
2 months ago - By: Zacks Investment Research
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
2 months ago - By: Zacks Investment Research
- Mentions:
MASI
EXAS
NVST
Should You Continue to Hold EXAS Stock in Your Portfolio?
2 months ago - By: Zacks Investment Research
- Mentions:
VREX
Phibro Animal Health Corporation (PAHC) Hit a 52 Week High, Can the Run Continue?
2 months ago - By: Zacks Investment Research
- Mentions:
ZBH
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
2 months ago - By: Zacks Investment Research
- Mentions:
MASI
NVST
GEHC
Here's Why You Should Add PAHC Stock to Your Portfolio Right Now
3 months ago - By: Zacks Investment Research
- Mentions:
MYGN
MEDP
NVST
MYGN Stock Might Gain on The Lancet Study Backing Precise MRD
3 months ago - By: Zacks Investment Research
- Mentions:
MYGN
MEDP
NVST
MYGN's GeneSight Test Proven Superior to TAU: Stock to Gain?
3 months ago - By: Zacks Investment Research
- Mentions:
HALO
LDOS
PDD
Zacks.com featured highlights include Halozyme Therapeutics, Phibro, Leidos and PDD Holdings
Please enable JavaScript to continue using this application.